MEDCu Technologies

What MEDCu Technologies does

MEDCu Technologies is an Israeli private medical device company founded in 2016 and headquartered in Herzliya. The company develops and commercializes advanced wound care dressings impregnated with copper oxide microparticles, leveraging copper's antimicrobial properties to accelerate healing and reduce infection rates in hard-to-heal and chronic wounds. Its offering consists of a single core product line — copper-infused wound dressings — positioned for hospitals, clinics, and healthcare institutions treating patients with chronic wounds, where slow healing and infection risk are primary pain points.

The company generates revenue through hardware/medical device sales of its dressings, distributed via an expanding international distribution network. Its go-to-market is enterprise-oriented, targeting healthcare providers and institutions through channel partners and direct sales. The product has received external validation through an Innovation Award at the 2025 US MedTech Summit, recognizing clinical promise and scalability.

MEDCu remains an early-stage private company: no revenue, funding rounds, headcount figures, or named distribution partners are disclosed in the available sources. The company is led by founder and CEO Danny Lustiger. Strategic posture is defined by ongoing international expansion of its distribution footprint as the primary growth lever, with limited disclosed evidence on ownership structure, regulatory clearances, or patent portfolio depth.

Name

MEDCu Technologies

Website

https://medcu.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

MEDCu Technologies is an Israeli medical device company that sells copper-oxide-infused wound dressings designed to accelerate healing and reduce infection in chronic and hard-to-heal wounds. It serves hospitals and clinics via an expanding international distribution network.

Ownership category

akta.pro rank

Product category

Wound Care Dressings

akta.pro primary industry

Antimicrobial Wound Care (Silver/Iodine/PHMB Dressings, Wound Irrigation) (HLAHALAC)

akta.pro secondary industries

Wound Care & Ulcer Management (HLAKACAN), Wound Care & Diabetic Foot Infection (HLAKAGAK)

Keywords

• Wound care dressings
• Antimicrobial wound dressings
• Copper oxide dressings
• Chronic wound treatment
• Medical device manufacturing

Headquarters

HQ city

Herzliya

HQ country

Israel

HQ region

Middle East

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Revenue generated from the sale of copper-infused wound care dressings to healthcare providers and institutions. The company is expanding international distribution suggesting a hardware/medical device sales model.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

MEDCu Technologies manufactures and sells copper-infused wound care dressings impregnated with copper oxide microparticles. These advanced wound dressings are designed for healthcare providers and institutions to accelerate healing and reduce infection rates in hard-to-heal and chronic wounds, leveraging copper's antimicrobial properties.

Product overview

MEDCu Technologies is a medical device company that offers a single core product line: copper-infused wound care dressings. These dressings are designed for the treatment of hard-to-heal wounds, leveraging copper's antimicrobial properties to accelerate healing and reduce infection risk. The company is expanding its international distribution reach.

Differentiator

Problem solved

Functional benefit

Products and services

• Copper-Infused Wound Care Dressings Advanced wound care dressings impregnated with copper oxide microparticles, designed to accelerate healing and reduce infection in hard-to-heal and chronic wounds. Sold to healthcare providers, hospitals, and clinics treating patients with complex wound care needs.

Quantifiable outcome

• Accelerated healing and reduced infection in hard-to-heal wounds

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Direct peers

• Smith & Nephew: Global medical device major with a substantial Advanced Wound Management portfolio (antimicrobial and moist wound-healing dressings). Directly comparable to MEDCu as both sell antimicrobial wound dressings into hospitals for chronic and hard-to-heal wounds.
• ConvaTec: Specialist wound care and ostomy company offering a broad range of advanced wound dressings, including antimicrobial options, sold to hospitals and home-care providers. Comparable to MEDCu on product category, end customers, and the antimicrobial wound-dressing value proposition.
• Mölnlycke Health Care: Swedish-headquartered wound care specialist whose Mepilex and other advanced dressings are widely used in chronic-wound management. Comparable to MEDCu on product type (advanced wound dressings) and target customer (hospitals treating chronic/hard-to-heal wounds).
• Coloplast: Danish medtech with a dedicated Wound & Skin Care business selling advanced dressings (including antimicrobial variants) into hospitals and home-care channels. Comparable to MEDCu on product category, antimicrobial positioning, and hospital customer base.
• Integra LifeSciences: US-listed medical device company with a meaningful Wound Care & Surgical Reconstruction franchise, including advanced and antimicrobial dressings. Comparable to MEDCu on product category, chronic-wound focus, and hospital channel.
• Organogenesis: Commercial-stage regenerative medicine company selling advanced wound care products (biologic skin substitutes and dressings) for chronic wounds such as diabetic foot ulcers. Comparable to MEDCu as another differentiated, higher-end wound-care entrant targeting hard-to-heal wounds in hospitals.
• MiMedx: US-listed company focused on regenerative wound care and surgical recovery using placental tissue allografts. Comparable to MEDCu as a specialized, single-platform wound-care company targeting chronic and hard-to-heal wounds with a differentiated technology.
• Argentum Medical: US-based manufacturer of silver-based antimicrobial wound dressings (Silverlon). Comparable to MEDCu as a focused antimicrobial wound dressing specialist using a metal-ion antimicrobial mechanism to address infection risk in chronic wounds.

Broad incumbents

• 3M Health Care (Solventum): Large diversified medical products company whose wound-care portfolio (including antimicrobial dressings) is one of several healthcare segments. Comparable to MEDCu as a broad incumbent with overlapping antimicrobial wound dressing offerings and far greater commercial reach.

Emerging players

• PolyNovo: Australian-listed medical device company with an advanced biodegradable wound dressing platform focused on complex wounds and burns. Comparable to MEDCu as a smaller, innovation-led wound-care company with a single differentiated platform addressing hard-to-heal wounds.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key highlights1 record

Customer concentration

• LinkedInlinkedin.com/company/medcu-technologies-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MEDCu Technologies